Cantitate/Preț
Produs
Total produse
Vezi coșul
Modulation of Protein Stability in Cancer Therapy de Kathleen Sakamoto

Modulation of Protein Stability in Cancer Therapy

Editat de Kathleen Sakamoto, Eric Rubin
en Limba Engleză Hardback – mai 2009

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 69721 lei  6-8 săpt.
  Springer – 29 oct 2010 69721 lei  6-8 săpt.
Hardback (1) 70403 lei  6-8 săpt.
  Springer – mai 2009 70403 lei  6-8 săpt.

Preț: 70403 lei

Preț vechi: 74108 lei
-5% Nou

Puncte Express: 1056
Preț estimativ în valută:
13478€ • 14010$ • 11175£

Carte tipărită la comandă

Livrare economică 07-21 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780387691435
ISBN-10: 038769143X
Pagini: 165
Ilustrații: X, 165 p. 35 illus.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.43 kg
Ediția:2009
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Ubiquitin Ligases and Cancer.- The 26S Proteasome as a Therapeutic Target in Cancer: Beyond Protease Inhibitors?.- Targeting HAUSP: Killing Two Birds with One Stone.- Modulation of Protein Stability: Targeting the VHL Pathway.- Interrelationship of the Fanconi Anemia/BRCA Pathway.- Targeting the Sumoylation Pathway.- Proteasome Inhibitors.- Targeting Deubiquitinating Enzymes.- Proteolysis Targeting Chimeric Molecules.

Textul de pe ultima copertă

This book contains chapters written by experts in the field of the ubiquitin proteasome system and cancer.  The authors have summarized current information on ubiquitin ligases and proteasomes as potential targets for cancer therapy. Topics covered in the book include an overview of ubiquitin ligases, deubiquitinating enzymes, and the proteasome.  Specific diseases resulting from deregulated ubiquitin ligases, such as Von-Hippel-Lindau disease and Fanconi anemia are also discussed.  Finally, novel approaches and drugs to target proteins involved in sumoylation, ubiquitination, and degradation are described.

Caracteristici

Chapters focus on the cellular and molecular mechanisms of various small-molecule compounds and inhibitors that target proteins that regulate the proteasome, ubiquitin ligases, ubiquitination pathway, and aggresome pathway in cancer